{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:07:28Z","timestamp":1794049648202,"version":"4.8.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118768","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T13:03:14Z","timestamp":1763470994000},"page":"118768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Combination of CBD with minor cannabinoid CBDV suppresses CXCR4 via CB2 receptor and alleviates colitis in mice"],"prefix":"10.1016","volume":"193","author":[{"given":"Anat","family":"Gelfand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5700-0947","authenticated-orcid":false,"given":"Elazar","family":"Besser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiri","family":"Procaccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0800-6935","authenticated-orcid":false,"given":"Jonathan","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miryam","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oded","family":"Kleifeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Meiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118768_bib1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/cmi.2017.134","article-title":"Chemokines in homeostasis and diseases","volume":"15","author":"Chen","year":"2018","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.biopha.2025.118768_bib2","doi-asserted-by":"crossref","first-page":"ii84","DOI":"10.1136\/ard.2004.028316","article-title":"Chemokines: role in inflammation and immune surveillance","author":"Moser","year":"2004","journal-title":"Ann. Rheum. Dis. 63"},{"key":"10.1016\/j.biopha.2025.118768_bib3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1568008043339712","article-title":"Chemokine-Chemokine Receptor Network in Immune Cell Trafficking","volume":"4","author":"Kim","year":"2004","journal-title":"Curr. Drug Targets Immune Endocr. Metab. Disord."},{"key":"10.1016\/j.biopha.2025.118768_bib4","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/stem.2054","article-title":"Concise review: CXCR4\/CXCL12 signaling in immature hematopoiesis\u2014lessons from pharmacological and genetic models","volume":"33","author":"Karpova","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.biopha.2025.118768_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.imlet.2019.11.007","article-title":"CXCL12\/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy","volume":"217","author":"Mousavi","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.biopha.2025.118768_bib6","doi-asserted-by":"crossref","first-page":"29338","DOI":"10.1038\/srep29338","article-title":"Immunophenotyping of rheumatoid arthritis reveals a linkage between HLA-DRB1 genotype, CXCR4 expression on memory CD4(+) T cells, and disease activity","volume":"6","author":"Nagafuchi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118768_bib7","article-title":"Emerging importance of chemokine receptor CXCR4 and its ligand in liver disease","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118768_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7150\/thno.5135","article-title":"Involvement of CXCR4\/CXCR7\/CXCL12 interactions in inflammatory bowel disease","volume":"3","author":"Werner","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.118768_bib9","first-page":"4821","article-title":"Functional characterization of CXCR4 in mediating the expression of protein C system in experimental ulcerative colitis","volume":"9","author":"Lin","year":"2017","journal-title":"Am. J. Transl. Res"},{"key":"10.1016\/j.biopha.2025.118768_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.trsl.2006.11.009","article-title":"Immune dysfunction in inflammatory bowel disease","volume":"149","author":"Neuman","year":"2007","journal-title":"Transl. Res."},{"key":"10.1016\/j.biopha.2025.118768_bib11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1189\/jlb.0111101","article-title":"Reciprocal regulation of CXCR4 and CXCR7 in intestinal mucosal homeostasis and inflammatory bowel disease","volume":"90","author":"Werner","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2025.118768_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/jpet.108.141085","article-title":"Blockade of CXCL12\/CXCR4 Axis Ameliorates Murine Experimental Colitis","volume":"327","author":"Mikami","year":"2008","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2025.118768_bib13","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.3748\/wjg.v16.i23.2873","article-title":"CXCR4 antagonist AMD3100 attenuates colonic damage in mice with experimental colitis","volume":"16","author":"Xia","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2025.118768_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027282","article-title":"CXCR4 antagonist AMD3100 modulates claudin expression and intestinal barrier function in experimental colitis","volume":"6","author":"Xia","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118768_bib15","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3390\/jcm14051536","article-title":"Paradigm shift in inflammatory bowel disease management: precision medicine, artificial intelligence, and emerging therapies","volume":"14","author":"Caballero Mateos","year":"2025","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.biopha.2025.118768_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-025-01063-x","article-title":"Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response","author":"Solitano","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2025.118768_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12149-018-1290-8","article-title":"CXCR4-directed theranostics in oncology and inflammation","volume":"32","author":"Kircher","year":"2018","journal-title":"Ann. Nucl. Med"},{"key":"10.1016\/j.biopha.2025.118768_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2219164","article-title":"Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression","volume":"12","author":"Wyrobnik","year":"2023","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2025.118768_bib19","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.2174\/138161206777947425","article-title":"Cannabinoids, immune system and cytokine network","volume":"12","author":"Massi","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2025.118768_bib20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1189\/jlb.0303101","article-title":"The cannabinoid system and immune modulation","volume":"74","author":"Klein","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2025.118768_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/can.2020.0105","article-title":"The effects of cannabinoids on pro- and anti-inflammatory cytokines: a systematic review of In Vivo studies","volume":"6","author":"Henshaw","year":"2021","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.biopha.2025.118768_bib22","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118768_bib23","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1002\/eji.201040667","article-title":"Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties","volume":"40","author":"Hegde","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2025.118768_bib24","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1476-5381.2011.01379.x","article-title":"Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL\/6 mice","volume":"163","author":"Kozela","year":"2011","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118768_bib25","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.18632\/oncotarget.26983","article-title":"The heterogeneity and complexity of Cannabis extracts as antitumor agents","volume":"10","author":"Baram","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118768_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41416-022-01727-4","article-title":"Cannabinoids as anticancer drugs: current status of preclinical research","volume":"127","author":"Hinz","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118768_bib27","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/MEG.0b013e328349bb4c","article-title":"Cannabis use amongst patients with inflammatory bowel disease","volume":"23","author":"Lal","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118768_bib28","article-title":"Cannabis use in patients with inflammatory bowel disease following legalization of cannabis in canada","volume":"360","author":"Iablokov","year":"2024","journal-title":"Crohns Colitis"},{"key":"10.1016\/j.biopha.2025.118768_bib29","article-title":"Cannabinoids for inflammatory bowel disease: a scoping review","author":"Brodaric","year":"2024","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.biopha.2025.118768_bib30","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.71068","article-title":"The potential of cannabis in managing inflammatory bowel disease and its future perspective","author":"Rauf","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.biopha.2025.118768_bib31","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ibd\/izy002","article-title":"A randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis","volume":"24","author":"Irving","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.biopha.2025.118768_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028159","article-title":"Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis","volume":"6","author":"De Filippis","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118768_bib33","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","article-title":"Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease","volume":"85","author":"Borrelli","year":"2013","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118768_bib34","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cgh.2013.04.034","article-title":"Cannabis induces a clinical response in patients with crohn\u2019s disease: a prospective placebo-controlled study","volume":"11","author":"Naftali","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2025.118768_bib35","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/ecco-jcc\/jjab069","article-title":"Oral CBD-rich cannabis induces clinical but not endoscopic response in patients with crohn\u2019s disease, a randomised controlled trial","volume":"15","author":"Naftali","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.biopha.2025.118768_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2021.685289","article-title":"Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis Consumption","volume":"12","author":"Tartakover Matalon","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118768_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2016.00341","article-title":"An orally active cannabis extract with high content in cannabidiol attenuates chemically-induced intestinal inflammation and hypermotility in the mouse","volume":"7","author":"Pagano","year":"2016","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118768_bib38","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/cells13191618","article-title":"The modulatory effects and therapeutic potential of cannabidiol in the gut","volume":"13","author":"Brown","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118768_bib39","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1039\/C6NP00074F","article-title":"Phytocannabinoids: a unified critical inventory","volume":"33","author":"Hanu\u0161","year":"2016","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.biopha.2025.118768_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-32651-4","article-title":"A new ESI-LC\/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis","volume":"8","author":"Berman","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118768_bib41","doi-asserted-by":"crossref","first-page":"894960","DOI":"10.3389\/fphar.2022.894960","article-title":"Cannabis for medical use: versatile plant rather than a single drug","volume":"13","author":"Procaccia","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118768_bib42","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","article-title":"Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease","volume":"85","author":"Borrelli","year":"2013","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118768_bib43","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00109-009-0512-x","article-title":"Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis","volume":"87","author":"Borrelli","year":"2009","journal-title":"J. Mol. Med"},{"key":"10.1016\/j.biopha.2025.118768_bib44","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.2147\/DDDT.S86345","article-title":"Gallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB\/c mice","author":"Pandurangan","year":"2015","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.biopha.2025.118768_bib45","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s12013-013-9604-x","article-title":"Resveratrol suppresses microcirculatory disturbance in a rat model of severe acute pancreatitis","volume":"67","author":"Sha","year":"2013","journal-title":"Cell Biochem Biophys."},{"key":"10.1016\/j.biopha.2025.118768_bib46","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/cac2.12422","article-title":"Antitumoral effects of cannabis in Notch1 -mutated T-cell acute lymphoblastic leukemia","volume":"43","author":"Besser","year":"2023","journal-title":"Cancer Commun."},{"key":"10.1016\/j.biopha.2025.118768_bib47","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.90854","article-title":"Cannabinoid combination targets NOTCH1-mutated T-cell acute lymphoblastic leukemia through the integrated stress response pathway","volume":"12","author":"Besser","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2025.118768_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.777804","article-title":"Minor cannabinoids: biosynthesis, molecular pharmacology and potential therapeutic uses","volume":"12","author":"Walsh","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118768_bib49","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/eji.200636821","article-title":"Chemokine receptor 4 (CXCR4) is part of the lipopolysaccharide \u201csensing apparatus\u201d","volume":"38","author":"Triantafilou","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2025.118768_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/19336918.2015.1134404","article-title":"LPS-induced CXCR4-dependent migratory properties and a mesenchymal-like phenotype of colorectal cancer cells","volume":"11","author":"Liu","year":"2017","journal-title":"Cell Adh Migr."},{"key":"10.1016\/j.biopha.2025.118768_bib51","doi-asserted-by":"crossref","first-page":"938","DOI":"10.4252\/wjsc.v12.i9.938","article-title":"Role of the CXCR4-SDF1-HMGB1 pathway in the directional migration of cells and regeneration of affected organs","volume":"12","author":"Haque","year":"2020","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.biopha.2025.118768_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2025.118768_bib53","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s10620-017-4540-z","article-title":"Low-dose cannabidiol is safe but not effective in the treatment for crohn\u2019s disease, a randomized controlled trial","volume":"62","author":"Naftali","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2025.118768_bib54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: \u0394 9-tetrahydrocannabinol, cannabidiol and \u0394 9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118768_bib55","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.bjp.0707523","article-title":"CB 2 receptor-mediated migration of immune cells: it can go either way","volume":"153","author":"Miller","year":"2008","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118768_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00744","article-title":"Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors","volume":"8","author":"Mart\u00ednez-Pinilla","year":"2017","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118768_bib57","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.2147\/JIR.S374692","article-title":"Cannabidiol inhibits inflammation induced by cutibacterium acnes-derived extracellular vesicles via activation of CB2 receptor in keratinocytes","volume":"15","author":"Jiang","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.biopha.2025.118768_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105769","article-title":"Cannabidiol prevents LPS-induced inflammation by inhibiting the NLRP3 inflammasome and iNOS activity in BV2 microglia cells via CB2 receptors and PPAR\u03b3","volume":"177","author":"Rodrigues","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2025.118768_bib59","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s13311-015-0374-6","article-title":"The endocannabinoid system and its modulation by phytocannabinoids","volume":"12","author":"Di Marzo","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2025.118768_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179472","article-title":"The endocannabinoid system: a potential target for the treatment of various diseases","volume":"22","author":"Lowe","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118768_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules26175352","article-title":"An evaluation of understudied phytocannabinoids and their effects in two neuronal models","volume":"26","author":"Straiker","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118768_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121336","article-title":"Cannabinoidomics \u2013 an analytical approach to understand the effect of medical cannabis treatment on the endocannabinoid metabolome","author":"Berman","year":"2020","journal-title":"Talanta"},{"key":"10.1016\/j.biopha.2025.118768_bib63","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1476-5381.2010.00791.x","article-title":"The effects of \u0394 9 -tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis","volume":"160","author":"Jamontt","year":"2010","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118768_bib64","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3390\/biomedicines10081793","article-title":"Differential effects of D9 tetrahydrocannabinol (THC)- and cannabidiol (CBD)-based cannabinoid treatments on macrophage immune function In Vitro and on gastrointestinal inflammation in a murine model","volume":"10","author":"Yekhtin","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2025.118768_bib65","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3390\/biom14111434","article-title":"Evaluation of the efficacy of a full-spectrum low-THC cannabis plant extract using in Vitro models of inflammation and excitotoxicity","volume":"14","author":"Ross-Munro","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2025.118768_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104464","article-title":"The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients","volume":"149","author":"Pagano","year":"2019","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2025.118768_bib67","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bcp.2018.06.025","article-title":"Appraising the \u201centourage effect\u201d: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer","volume":"157","author":"Blasco-Benito","year":"2018","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118768_bib68","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3389\/fneur.2018.00759","article-title":"Potential clinical benefits of CBD-rich cannabis extracts over purified CBD in treatment-resistant epilepsy: observational data","volume":"9","author":"Pamplona","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.biopha.2025.118768_bib69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000521683","article-title":"Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals","volume":"107","author":"Legare","year":"2022","journal-title":"Pharmacology"},{"key":"10.1016\/j.biopha.2025.118768_bib70","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/ibd\/izad151","article-title":"The impact of cannabis use on clinical outcomes in inflammatory bowel disease: a population-based longitudinal cohort study","volume":"30","author":"Glickman","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.biopha.2025.118768_bib71","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/nu16010078","article-title":"Medical cannabis increases appetite but not body weight in patients with inflammatory bowel diseases","volume":"16","author":"Fliss Isakov","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2025.118768_bib72","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13756","article-title":"Effects of O-1602 and CBD on TNBS-induced colonic disturbances","volume":"32","author":"Wei","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.biopha.2025.118768_bib73","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/jpet.124.002204","article-title":"High cannabigerol hemp extract moderates colitis and modulates the microbiome in an inflammatory bowel disease model","volume":"390","author":"Anderson","year":"2024","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2025.118768_bib74","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.molimm.2006.01.005","article-title":"Cannabinoid receptor CB2 modulates the CXCL12\/CXCR4-mediated chemotaxis of T lymphocytes","volume":"43","author":"Ghosh","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biopha.2025.118768_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023901","article-title":"Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion","volume":"6","author":"Nasser","year":"2011","journal-title":"PLOS One"},{"key":"10.1016\/j.biopha.2025.118768_bib76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5217\/ir.2012.10.2.125","article-title":"Role of the CXC12-CXCR4 Axis and CXCL16 in inflammatory bowel disease","volume":"10","author":"Nakase","year":"2012","journal-title":"Intest. Res."},{"key":"10.1016\/j.biopha.2025.118768_bib77","article-title":"Discovery of dibenzyl amide derivatives as novel CXCR4 modulators against inflammatory bowel disease","volume":"10","author":"Jiang","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500962X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500962X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:48:13Z","timestamp":1777013293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500962X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":77,"alternative-id":["S075333222500962X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118768","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of CBD with minor cannabinoid CBDV suppresses CXCR4 via CB2 receptor and alleviates colitis in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118768"}}